Fringilla’s main target is ethical investments.
Fringilla was started in 1986 to deliver consultancy services within management and computing. The name in Norwegian is bokfink, suggesting books, chaffinch in English.
2007-2010 the company participated in developing what became ISO 26000, a standard for Social Responsibility, an international effort including 100 countries.
2010 the master level course Cyberethics was started, partly based on ISO 26000 and including social responsibility in ethics, along with systems theory.
2012 the seminar Ethical Management was started addressing the need for ethics in management. Already there were many instances of bad management due to missing or faulty ethics.
2015 two books were published by Fringilla, first Ethics that was textbook for Cyberethics and may be called Aristotle 2.0, a significant extension of Ethics. The other book is based partly on Ethics, named Helseledelse in Norwegian, in English Health Management. Ethics was the textbook of Cyberethics, Health management was selected because it was the management extreme sport, with many deviations from traditional management, for instance that products are produced. Health is service with quite different challenges.
2018 Ethical Management was published, trying to establish a new management theory targeting the modern world. Main parts are creativity, service management, Nordic management and modern governance. Ethical Management is not only daily management, but also planning, development, quality, security, trust and ethics. Thus tuition may need to be extended. Modern medicine can be an inspiration, with rigorous education, good textbooks and competent teachers.
More and more ethical investments became the main source of income for Fringilla, based mostly on ISO 26000.
Below some examples of green investments, at the same time high technology:
Algeta, a Norwegian startup, developed treatment for prostate cancer. Radium is sent to the cancer, the purpose is to kill the cancer by radiation. Treatment is thus limited to the cancer, affecting the rest of the patient very little. Algeta was sold to Bayer for 3 billion dollars, but research continues to replace radium by a more powerful agent and to extend to all types of cancer.
Nordic Semiconductor was started by Norwegian students in 1983, works in all parts of the world and has won many prices. The primary targets have been Bluetooth and low energy applications within Internet of Things. In 2019 an integrated system-on-a-chip was launched and has been well received. In 2020 their strongest growth is in health, and they participate to help fight Corona.
In July 2020 their share price had increased 110% for the last 12 months.
BerGenBio is a Norwegian biotechnology firm mainly in cancer research. In their Bemcentinib they strengthen the immune defence of the body and at the same time reduce the defences of the cancer. Bemcentinib was the first treatment to be included in the UK’s ACCORD program against Corona.
July 2020 the share value had increased 178% for the last 12 months.
In comparison Norwegian industrial Equinor fell 17% in the same period and Hydro fell 7%. This does not prove ethical investment, but is an indication that it should be investigated.
The green fund DNB grønt Norden increased value by 35% in 2019.
Background for owner Tore Audun Høie:
Civil Engineer Heriot Watt University, Scotland, management diploma Heriot Watt University, PhD Danmarks Tekniske Universitet.